Brain, sleep, cancer: the 7 promises of GLP-1

September 21, 2024

news

You can also find out more about Par Editor You can also find out more about the following: 21.09.2024 at 06:00 Reading 15 min. Subscribers

GLP-1 analogues, which have so far only been used to treat diabetes and obesity, could prove beneficial for many other diseases. Here's a look at the outlook.

A woman holds an Ozempic needle pen.

Jaap arriens / NurPhoto / NurPhoto by AFP

This article is taken from the monthly Sciences et Avenir – La Recherche ndeg931, dated September 2024.

For about a year, not a month has gone by without one or more studies reporting the exploration of new potentially beneficial effects – or not – of GLP-1 analogue drugs, currently only indicated for diabetes or certain cases of obesity. In 2023, some 2,200 publications were referenced, also taking into account those that explore the risks of adverse effects. A figure that is well on its way to exceeding 3,000 in 2024.

GLP-1 The following are some of the ways to reduce your risk: Type 2 diabetes Obesity Parkinson's disease